W. Compton
Epidemiology · 2004–2017
A researcher in the Science corpus: 10 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 29 citations into it
- Pathology and Forensic Medicine — 9 citations into it
- Experimental and Cognitive Psychology — 7 citations into it
Whom W. Compton trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts W. Compton overall
Papers from W. Compton's perspective
Ordered by how strongly the researchers W. Compton trusts endorse each paper. Same corpus, a different order for every researcher.
- The comorbidity of depression and substance use disorders. (Clinical Psychology Review)
- Cost of lost productive work time among US workers with depression. (Journal of the American Medical Association (JAMA))
- Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications (Nature Reviews Neuroscience)
- Caffeinated Energy Drinks -- A Growing Problem (Drug and Alcohol Dependence)
- Fetal Alcohol Spectrum Disorders: Neuropsychological and Behavioral Features (Neuropsychology Review)
- Neurobiology of the incubation of drug craving (Trends in Neurosciences)
- AUDIT - The alcohol use disorders identification test: guidelines for use in primary care.
- The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (Journal of Clinical Psychiatry)
- A Norwegian psychiatric epidemiological study. (American Journal of Psychiatry)
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. (The Lancet)
Their papers
- Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health (2017) — 718 citations
- Design and methods of the Population Assessment of Tobacco and Health (PATH) Study (2016) — 747 citations
- Relationship between Nonmedical Prescription-Opioid Use and Heroin Use (2016) — 1,000 citations
- Adverse Health Effects of Marijuana Use (2014) — 2,425 citations
- DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale (2013) — 1,376 citations
- Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and six months (2008) — 681 citations
- Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. (2007) — 1,115 citations
- Major increases in opioid analgesic abuse in the United States: concerns and strategies. (2006) — 823 citations
- Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. (2006) — 915 citations
- Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders (2004) — 1,893 citations